surmount-1 trial tirzepatide weight loss nondiabetic 🔴Tirzepatide for obesity and diabetes prevention ⤵️ progression to T2D in prediabetes❗️#SURMOUNT1 trial‼️ 🔹 Up to 20% over 3 years with tirzepatide, reducing T2D onset by 93% vs. placebo. 🔹After Tirzepatide for the Maintenance of
Description
For more on what to anticipate, see what to expect after your first dose of tirzepatide

So Long, Saggy Thighs- Hello, Slim & Contour You should be able to celebrate your weight loss achievement without the problem of loose skin, discomfort, or feeling the need to hide under layers of clothing
Average 71.2 pounds of weight loss in the TRIUMPH-4 trial
00656-2/asset/38c98550-9ec2-44e8-ba6a-dbb815075666/main.assets/gr1_lrg.jpg)
The net effect is that patients feel full sooner, stay full longer and eat less

While both drugs are effective, adding a third hormone (Glucagon) in Retatrutide brings a different side effect profile that researchers are still studying
